Asthma, Aspirin-Induced - 9 Studies Found
| Not yet recruiting | 
                                    : Role of Inflammatory Mediators in AERD : Asthma, Aspirin-Induced : 2016-06-24 : Drug: aspirin  | 
                                
| Completed | 
                                    : The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases : Asthma, Aspirin-Induced : 2013-05-29 : Drug: aspirin  | 
                                
| Not yet recruiting | 
                                    : Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) : Asthma, Aspirin-Induced : 2017-01-19 : 
  | 
                                
| Active, not recruiting | 
                                    : Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease : Asthma, Aspirin-induced : 2011-03-17  | 
                                
| Active, not recruiting | 
                                    : Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) : 
 : 2012-04-30 : Drug: Prasugrel Participants will take a 60 mg loading dose. After they will take 10 mg by mouth daily i  | 
                                
| Active, not recruiting | 
                                    : Challenge Test for Acetylsalicylic Acid Hypersensitivity : 
  | 
                                
| Recruiting | 
                                    : High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) : 
 : 2014-02-14 : Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams  | 
                                
| Completed | 
                                    : Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease : Aspirin Exacerbated Respiratory Disease (AERD) : 2014-08-12 : 
  | 
                                
| COMPLETED | 
                                    : Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) : Asthma, Aspirin-Induced : 2025-11-04 : Solution.Subcutaneous.Mepolizumab is a biological drug, a humanized monoclonal antibody against interleukin-5.  |